Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Cools, Roshan
Barker, Roger A
Sahakian, Barbara J
and
Robbins, Trevor W
2003.
l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease.
Neuropsychologia,
Vol. 41,
Issue. 11,
p.
1431.
Feeney, Farah
Egan, Sarah
and
Gasson, Natalie
2005.
Treatment of depression and anxiety in Parkinson's Disease: A pilot study using group cognitive behavioural therapy.
Clinical Psychologist,
Vol. 9,
Issue. 1,
p.
31.
McNamara, Patrick
Durso, Raymon
and
Harris, Erica
2006.
Life goals of patients with Parkinson’s disease: a pilot study on correlations with mood and cognitive functions.
Clinical Rehabilitation,
Vol. 20,
Issue. 9,
p.
818.
McNamara, Patrick
Durso, Raymon
and
Brown, Ariel
2006.
Religiosity in patients with Parkinson's disease.
Neuropsychiatric Disease and Treatment,
Vol. 2,
Issue. 3,
p.
341.
McNamara, Patrick
Durso, Raymon
and
Harris, Erica
2007.
“Machiavellianism” and frontal dysfunction: Evidence from Parkinson's disease.
Cognitive Neuropsychiatry,
Vol. 12,
Issue. 4,
p.
285.
Levin, O. S.
2007.
Coaxil (tianeptine) in the treatment of depression in Parkinson’s disease.
Neuroscience and Behavioral Physiology,
Vol. 37,
Issue. 4,
p.
419.
Paelecke-Habermann, Yvonne
Ebersbach, Georg
and
Leplow, Bernd
2007.
Depressivität und Depression bei der Parkinson-Erkrankung.
Zeitschrift für Neuropsychologie,
Vol. 18,
Issue. 3,
p.
207.
2008.
Neuropsychological Neurology.
p.
1.
2008.
Neuropsychological Neurology.
p.
6.
2008.
Neuropsychological Neurology.
p.
39.
Mace, JL
Porter, RJ
Dalrymple-Alford, JC
and
Anderson, TJ
2010.
The effects of acute tryptophan depletion on mood in patients with Parkinson’s disease and the healthy elderly.
Journal of Psychopharmacology,
Vol. 24,
Issue. 4,
p.
615.
McNamara, Patrick
Stavitsky, Karina
Harris, Erica
Szent‐Imrey, Orsolya
and
Durso, Raymon
2010.
Mood, side of motor symptom onset and pain complaints in Parkinson's disease.
International Journal of Geriatric Psychiatry,
Vol. 25,
Issue. 5,
p.
519.
Jorge, Ricardo E
Starkstein, Sergio E
and
Robinson, Robert G
2010.
Apathy following Stroke.
The Canadian Journal of Psychiatry,
Vol. 55,
Issue. 6,
p.
350.
Levin, O. S.
Batukaeva, L. A.
Anikina, M. A.
and
Yunishchenko, N. A.
2011.
Efficacy and safety of choline alphoscerate (cereton) in patients with parkinson’s disease with cognitive impairments.
Neuroscience and Behavioral Physiology,
Vol. 41,
Issue. 1,
p.
47.
Cruise, K. E.
Bucks, R. S.
Loftus, A. M.
Newton, R. U.
Pegoraro, R.
and
Thomas, M. G.
2011.
Exercise and Parkinson’s: benefits for cognition and quality of life.
Acta Neurologica Scandinavica,
Vol. 123,
Issue. 1,
p.
13.
Mørkeberg Nilsson, Flemming
2012.
Parkinson’s disease and affective disorder: The temporal relationship.
Open Journal of Psychiatry,
Vol. 02,
Issue. 02,
p.
96.
2013.
Neuropsychological Neurology.
p.
1.
Cavanna, Andrea E.
2018.
Motion and Emotion.
p.
83.
Assogna, Francesca
Pellicano, Clelia
Savini, Cinzia
Macchiusi, Lucia
Pellicano, Gaia R.
Alborghetti, Marika
Caltagirone, Carlo
Spalletta, Gianfranco
and
Pontieri, Francesco E.
2020.
Drug Choices and Advancements for Managing Depression in Parkinson's Disease.
Current Neuropharmacology,
Vol. 18,
Issue. 4,
p.
277.